Drugs / Novel FAP-targeted probe
Novel FAP-targeted probe
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07707999 | Jul → Sep 2026 overdue | cancer | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Novel FAP-targeted probe | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07707999 ↗ |
| Modality | Diagnostic / imaging agent | “This study utilizes a FAP-specific PET/SPECT imaging probe to evaluate the feasibility, accuracy, and clinical value in malignant neoplasm.” NCT07707999 ↗ |
| Route | Intravenous | “single low-dose intravenous injection” NCT07707999 ↗ |